Bisphosphonate prescribing in chronic kidney disease

Journal of the Royal College of Physicians of Edinburgh

Volumn 39, Issue 1, 2009, Pages 4-9

  Courtney, A E ^a   Leonard, N ^b   McCloskey, M C ^b   Smyth, J S ^b   Maxwell, A P ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b ULSTER HOSPITAL   (United Kingdom)

Author keywords

Bisphosphonate; Chronic kidney disease; Osteoporosis; Prescribing; Renal bone disease

Indexed keywords

ALENDRONIC ACID; AREDIA DRY POWDER; BISPHOSPHONIC ACID DERIVATIVE; BODRONAT; CLODRONIC ACID; CORTICOSTEROID; ETIDRONIC ACID; IBANDRONIC ACID; LORON; PAMIDRONIC ACID; RISEDRONIC ACID; TILUDRONIC ACID; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; TREATMENT INDICATION; TREATMENT RESPONSE; UNITED KINGDOM;

EID: 67649680430     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Hruska KA, Teitelbaum SL. Renal osteodystrophy. N Engl J Med 1995; 333:166-74.
2. Miller PD. Is there a role for bisphosphonates in chronic kidney disease? Semin Dial 2007; 20:186-90.
3. National Institute for Health and Clinical Excellence. Osteoporosis - secondary prevention including strontium ranelate. London: NICE; 2005. Available from: http://www.nice.org.uk/Guidance/TA161
4. British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary. London: BMA/RPSGB; 2008.
5. Miller PD. Treatment of metabolic bone disease in patients with chronic renal disease: a perspective for rheumatologists. Curr Rheumatol Rep 2005; 7:53-60.
6. Troehler U, Bonjour JP, Fleisch H. Renal transport of bisphosphonates: accumulation by renal cortical slices enhanced by calcium phosphate ions. J Lab Clin Med 1985; 106:23-9.
7. Markowitz GS, Appel GB, Fine PL et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 2001; 12:1164-72.